Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00754507 · ClinicalTrials.gov registry record · Phase 4
A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.
A Phase 4 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 4
- Development phase
- 65
- Enrollment target
NCT00754507 is a Phase 4 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 65 participants.
The verdict
NCT00754507, a Phase 4 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 65 participants
- Enrollment target
Study Summary
To determine the effects of WelChol tablets on serum lipids, lipoproteins, apolipoproteins, and lipoprotein particle size in patients who were stabilized on atorvastatin therapy for at least 4 weeks.
Interventions
- DRUG colesevelam HCl tablets, and atorvastatin tablets
- DRUG colesevelam HCl placebo tablets and atorvastatin tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2002-11 |
| Est. Completion | 2005-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00754507
The ClinicalTrials.gov registry entry for NCT00754507 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which colesevelam HCl tablets, and atorvastatin tablets is the first listed.
NCT00754507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00754507 about?
NCT00754507 is a clinical study titled "A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.". To determine the effects of WelChol tablets on serum lipids, lipoproteins, apolipoproteins, and lipoprotein particle size in patients who were stabilized on atorvastatin therapy for at least 4 weeks.
What is the current status of trial NCT00754507?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 65 participants. The study started on 2002-11. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00754507?
The interventions under investigation include: colesevelam HCl tablets, and atorvastatin tablets (DRUG), colesevelam HCl placebo tablets and atorvastatin tablets (DRUG).
Who is sponsoring clinical trial NCT00754507?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.